Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Combined analysis of preoperative and postoperative lymphocyte-C-reactive protein ratio precisely predicts outcomes of patients with gastric cancer

Fig. 3

Survival curves according to the postoperative LCR of patients with pre-LCRHigh (a) and those with pre-LCRL°w (b). The 5 year survival among patients with pre-LCRHigh and post-LCRHigh and among those with pre-LCRHigh and post-LCRL°w did not differ significantly (84.8% vs. 81.2%, p = 0.205). On the contrary, the 5 year survival rate was significantly worse in patients with pre-LCRL°w and post-LCRL°w than in those with pre-LCRL°w and post-LCR.High (52.0% vs. 81.6%, p < 0.0001)

Back to article page